Literature DB >> 35441910

Heart rate variability in men with lower urinary tract symptoms: a case-control study.

Christiano Silva Brum1, Daniel Rocha Pedrosa1, Isabel Cristina Gonçalves Leite2, José Murillo Bastos Netto1,3, André Avarese Figueiredo4,5.   

Abstract

PURPOSE: Measurement of heart rate variability (HRV) allows evaluation of autonomic nervous system activity. Decreased HRV is associated with autonomic disbalance, poor health and higher mortality. Our objective is to evaluate the HRV in men with lower urinary tract symptoms (LUTS) through a case-control study.
METHODS: LUTS were considered as the outcome and HRV variables were considered as exposure. The protocol included anamnesis, LUTS assessment, anthropometry, blood pressure and HRV measurement by analyzing the variation in the time interval between consecutive heartbeats or RR intervals. The mathematical study of HRV indicators allowed the assessment of the cardiac autonomic modulation of the volunteers.
RESULTS: Eighty nine patients were included in the study, with 34 allocated to the case group (with LUTS) and 55 to the control group (without LUTS). The patients were similar in terms of age and systolic and diastolic blood pressure. Among the HRV variables, the mean VLF index for the very low frequency of the spectrum associated with the frequency domain was significantly higher in volunteers without LUTS. Control group patients presented a mean of 113.18 ± 166.74 ms2, while patients with LUTS presented a mean of 69.21 ± 61.98 ms2 (p = 0.032).
CONCLUSIONS: Men 50-59 years of age without chronic diseases and with LUTS have an unfavorable cardiac autonomic profile indicated by significantly lower levels of the VLF component of HRV compared to men without LUTS.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Autonomic modulation; Heart rate variability; Lower urinary tract symptoms

Mesh:

Year:  2022        PMID: 35441910     DOI: 10.1007/s11255-022-03213-5

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  1 in total

1.  Therapeutic trial of amitryptiline in the treatment of nocturnal enuresis--a controlled study.

Authors:  P C Mishra; V K Agarwal; H Rahman
Journal:  Indian Pediatr       Date:  1980-03       Impact factor: 1.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.